VAERS Explorer
Back to explore

Report #2835154

Received Apr 9, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
VA
Recovered
Unknown
Vaccinated
Mar 17, 2025
Onset
Mar 17, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
MMRMEASLES + MUMPS + RUBELLA (PRIORIX)GLAXOSMITHKLINE BIOLOGICALSUNK3ZE3E—

Symptoms (1)

Product preparation issue

Symptom narrative

administered only the diluent; administered only the diluent; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 56-year-old male patient who received MMR (Priorix) (batch number 3ZE3E, expiry date 22-NOV-2028) for prophylaxis. On 17-MAR-2025, the patient received Priorix. On 17-MAR-2025, an unknown time after receiving Priorix, the patient experienced inappropriate dose of vaccine administered (Verbatim: administered only the diluent ) and inappropriate preparation of medication (Verbatim: administered only the diluent ). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 19-MAR-2025 Reporter stated that they administered only the diluent (sterile water) without mixing with the powder (lyophilized part) of Priorix. Also asked if can it be diluted with other sterile water. The patient received only adjuvant of Priorix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. This case is linked with the case US2025033666,reported by the same reporter.; Sender's Comments: US-GSK-US2025033666:Same reporter/Different patient